Jin Medical International Ltd. (NASDAQ:ZJYL - Get Free Report) was the target of a significant growth in short interest in October. As of October 15th, there was short interest totalling 2,700,000 shares, a growth of 126.9% from the September 30th total of 1,190,000 shares. Approximately 7.1% of the shares of the company are sold short. Based on an average daily volume of 255,400 shares, the short-interest ratio is presently 10.6 days.
Jin Medical International Trading Down 3.1 %
NASDAQ:ZJYL traded down $0.07 during mid-day trading on Friday, reaching $2.18. 447,076 shares of the stock were exchanged, compared to its average volume of 376,693. Jin Medical International has a 1 year low of $0.42 and a 1 year high of $25.49. The company has a 50 day simple moving average of $2.71 and a 200-day simple moving average of $2.99.
About Jin Medical International
(
Get Free Report)
Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China.
Recommended Stories
Before you consider Jin Medical International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jin Medical International wasn't on the list.
While Jin Medical International currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
